Nascent Biotech Inc. (NBIO) SEC Filing 10-K Annual Report for the fiscal year ending Thursday, March 31, 2022

SEC Filings

NBIO Annual Reports

Nascent Biotech Inc.

CIK: 1622057 Ticker: NBIO
Cover - USD ($)
12 Months Ended
Mar. 31, 2022
Jun. 15, 2022
Sep. 30, 2021
Cover [Abstract]   
Entity Registrant NameNASCENT BIOTECH INC.  
Entity Central Index Key0001622057  
Document Type10-K  
Amendment Flagfalse  
Entity Voluntary FilersNo  
Current Fiscal Year End Date--03-31  
Entity Well Known Seasoned IssuerNo  
Entity Small Businesstrue  
Entity Shell Companyfalse  
Entity Emerging Growth Companyfalse  
Entity Current Reporting StatusYes  
Document Period End DateMar. 31, 2022  
Entity Filer CategoryNon-accelerated Filer  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Entity Common Stock Shares Outstanding 115,013,175 
Entity Public Float  $ 6,922,180
Document Annual Reporttrue  
Document Transition Reportfalse  
Entity File Number000-55299  
Entity Incorporation State Country CodeNV  
Entity Tax Identification Number46-5001940  
Entity Interactive Data CurrentYes  
Entity Address Address Line 1623 17th Street Suite 4  
Entity Address City Or TownVero Beach  
Entity Address Postal Zip Code32960  
City Area Code612  
Local Phone Number961-5656  
Entity Address State Or ProvinceFL  
Auditor NameSpokane  
Auditor LocationWashington  
Auditor Firm Id5525  

View differences made from one year to another to evaluate Nascent Biotech Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nascent Biotech Inc..


Assess how Nascent Biotech Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nascent Biotech Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Nascent Biotech Inc. provided additional information to their SEC Filing as exhibits

Ticker: NBIO
CIK: 1622057
Form Type: 10-K Annual Report
Accession Number: 0001477932-22-004396
Submitted to the SEC: Wed Jun 15 2022 3:37:01 PM EST
Accepted by the SEC: Wed Jun 15 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: